Recent Finacing
Recent Raise
Immune Design is a clinical-stage biotech developing vaccines and immunotherapies using a dendritic-cell-targeted lentiviral delivery platform (DCVex/DC‑NILV) and a synthetic TLR4 agonist adjuvant (GLA/GLAAS) for cancer and infectious diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors